Trial intelligence / Profile preview

UDCA for intrahepatic cholestasis of pregnancy

2014-004478-41Phase 3Completed

Sponsor
King's College London
Start
Mar 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in intrahepatic cholestasis of pregnancy (ICP) comparing Ursodeoxycholic acid with Placebo (2 arms). Primary endpoint: Composite short-term perinatal outcome. Started Mar 2015; status: completed.

02

Drugs

ursodeoxycholic acid
03

Conditions

intrahepatic cholestasis of pregnancy (ICP)

Beyond the preview

Go deeper on 2014-004478-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-004478-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call